MAYO CLINIC

Funding Organization

Awards Grant

  • A Randomized Controlled Trial of Rituximub versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)
  • ACOSOG Communtiy Clinical Oncology Program (CCOP) Research Base
  • ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) - Clinical Core
  • ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) - Clinical Core
  • Alliance NCORP Research Base - Alliance A171603 Pilot Study
  • Alliance for Clinical Trials in Oncology Payment Agreement
  • Alliance for Clinical Trials in Oncology Payment Agreement
  • Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)
  • Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)
  • Development of Novel Chemopreventive Interventions
  • Frontiers in Congenital Disorders of Glycosylation (Diagnosis and Biomarker Discovery)
  • Hereditary Causes of Nephrolithiasis and Kidney Failure
  • Hereditary Causes of Nephrolitiasis and Kidney Failure
  • Inhibition of Oxalate Synthesis by RNA Interference Rare Kidney Stone Consortium
  • Monitoring and Reporting of Alirocumab use in CREST-2
  • Multicenter Study of The Impact of Cytogenetic Abnormalities in Patients with Light Chain Amyloidosis
  • Myocardial Repair with a Novel Engineered Cardiac Muscle Patch
  • Polycystic Kidney Disease: Innovative Imaging to Assess Progression (PCC)
  • Serum Interferon Alpha/Beta Ratio as a Predictor of Response to Anti-TNF Alpha Therapy
  • Shared Decision Making for Stroke Prevention in Atrial Fibrillation (SDM4AFIB)
  • The Health Status of Caucasian and African American Living Kidney Donors
  • VIRUS-Viral Infection and Respiratory Illness Universal Study: COVID-19 Registry and Validation of C2D2 ( Critical Care Date Dictionary)